edaravone has been researched along with Severe Acute Respiratory Syndrome in 1 studies
Severe Acute Respiratory Syndrome: A viral disorder characterized by high FEVER, dry COUGH, shortness of breath (DYSPNEA) or breathing difficulties, and atypical PNEUMONIA. A virus in the genus CORONAVIRUS is the suspected agent.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Reznik, SE | 1 |
| Tiwari, AK | 1 |
| Ashby, CR | 1 |
1 other study available for edaravone and Severe Acute Respiratory Syndrome
| Article | Year |
|---|---|
Edaravone: A potential treatment for the COVID-19-induced inflammatory syndrome?
Topics: Betacoronavirus; Coronavirus Infections; COVID-19; Edaravone; Humans; Pandemics; Pneumonia, Viral; S | 2020 |